Generic Fights To Revoke J&J Prostate Cancer Drug Patent
Generic-drug maker Accord Healthcare has sued Janssen Oncology in a bid to invalidate the Johnson & Johnson subsidiary's patent for a prostate cancer treatment, saying it should be revoked because the...To view the full article, register now.
Already a subscriber? Click here to view full article